FN14 Signaling Plays a Pathogenic Role in a Mouse Model of Experimental Autoimmune Myocarditis

Area of Science:

• Immunology
• Cardiology
• Molecular Biology

Background:

• Autoimmune reactions contribute to inflammatory cardiomyopathy pathogenesis.
• An experimental autoimmune myocarditis (EAM) model was developed using troponin I (TnI).
• Fibroblast growth factor-inducible 14 (FN14) is implicated in autoimmune disorders.

Purpose of the Study:

• To investigate the role of FN14 in the development of autoimmune myocarditis.
• To determine the therapeutic potential of targeting FN14 in inflammatory cardiomyopathy.

Main Methods:

• Induced autoimmune myocarditis in wild-type (wt) and FN14 knockout (ko) mice via TnI immunization.
• Assessed cardiac function, myocardial injury, inflammation, and fibrosis.
• Analyzed myocardial expression of inflammatory mediators and signaling pathways (NF-κB).

Main Results:

• TnI immunization increased myocardial FN14 expression in wt mice.
• FN14 deficiency significantly improved cardiac performance and reduced inflammation, fibrosis, and damage.
• FN14ko mice showed lower expression of inflammatory cytokines and chemokines.

Conclusions:

• FN14 plays a critical role in amplifying the inflammatory response in autoimmune myocarditis.
• Inhibition of FN14 attenuates cardiac inflammation and injury.
• Targeting FN14 presents a promising therapeutic strategy for inflammatory cardiomyopathy.